SNN saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 51 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 62%.
The 10-day RSI Indicator for SNN moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 20 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Moving Average Convergence Divergence Histogram (MACD) for SNN turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 23 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
SNN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
SNN moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SNN crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNN advanced for three days, in 191 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 116 of 202 cases where SNN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. SNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.517) is normal, around the industry mean (4.142). P/E Ratio (20.991) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.035) is also within normal values, averaging (11.253). Dividend Yield (0.038) settles around the average of (0.011) among similar stocks. P/S Ratio (1.905) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ZBH saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 52 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 60%.
The 10-day RSI Indicator for ZBH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 19 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.
The Moving Average Convergence Divergence Histogram (MACD) for ZBH turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 25 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
ZBH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
ZBH moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ZBH crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.
Following a +1.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZBH advanced for three days, in 201 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 125 of 221 cases where ZBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. ZBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.595) is normal, around the industry mean (4.142). P/E Ratio (25.629) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.576) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (2.233) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SNN | ZBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 80 | |
PRICE GROWTH RATING 1..100 | 51 | 30 | |
P/E GROWTH RATING 1..100 | 80 | 28 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SNN's Valuation (54) in the Medical Specialties industry is in the same range as ZBH (67). This means that SNN’s stock grew similarly to ZBH’s over the last 12 months.
SNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ZBH (100). This means that SNN’s stock grew similarly to ZBH’s over the last 12 months.
ZBH's SMR Rating (80) in the Medical Specialties industry is in the same range as SNN (92). This means that ZBH’s stock grew similarly to SNN’s over the last 12 months.
ZBH's Price Growth Rating (30) in the Medical Specialties industry is in the same range as SNN (51). This means that ZBH’s stock grew similarly to SNN’s over the last 12 months.
ZBH's P/E Growth Rating (28) in the Medical Specialties industry is somewhat better than the same rating for SNN (80). This means that ZBH’s stock grew somewhat faster than SNN’s over the last 12 months.
| SNN | ZBH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 59% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 62% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 46% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 56% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 59% | 2 days ago 58% |
| Advances ODDS (%) | 24 days ago 58% | 4 days ago 68% |
| Declines ODDS (%) | 3 days ago 56% | 2 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 41% | 2 days ago 55% |
| Aroon ODDS (%) | 2 days ago 57% | 2 days ago 57% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SNN’s FA Score shows that 0 FA rating(s) are green while ZBH’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SNN’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 5 bullish TA indicator(s).
SNN (@Medical/Nursing Services) experienced а -4.64% price change this week, while ZBH (@Medical/Nursing Services) price change was -2.04% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -11.44%. For the same industry, the average monthly price growth was -15.18%, and the average quarterly price growth was -18.29%.
SNN is expected to report earnings on Feb 23, 2027.
ZBH is expected to report earnings on Feb 11, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, SNN has been loosely correlated with ZBH. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then ZBH could also see price increases.
A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with SYK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then SYK could also see price increases.
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| STRK.X | 0.030486 | -0.001151 | -3.64% |
| Starknet cryptocurrency | |||
| QKC.X | 0.001853 | -0.000071 | -3.69% |
| QuarkChain cryptocurrency | |||
| ONT.X | 0.034050 | -0.001873 | -5.21% |
| Ontology cryptocurrency | |||
| ACM.X | 0.201961 | -0.011870 | -5.55% |
| AC Milan Fan Token cryptocurrency | |||
| OM.X | 0.002010 | -0.023218 | -92.03% |
| MANTRA (old) cryptocurrency | |||